Bioequivalence and Bioavailability Forum

What to do with Whole period (Test or reference) is zero Mohamed Yehia 2017-12-13 16:37
- What to do with Whole period (Test or reference) is zero DavidManteigas 2017-12-13 16:51
- What to do with Whole period (Test or reference) is zero mittyri 2017-12-16 22:44

In-vitro equilibrium binding and kinetic binding study Mahesh M 2014-01-21 11:11
- In-vitro equilibrium binding and kinetic binding study Vineeth KE 2017-12-13 07:11

BE studies in Belarus_register Beholder 2017-12-11 14:33
- BE studies in Belarus_register Yura 2017-12-12 09:01
  - BE studies in Belarus_register Beholder 2017-12-12 09:11
    - BE studies in Belarus_register Yura 2017-12-12 09:25
      - BE studies in Belarus_register Beholder 2017-12-12 13:30

Generic product of fixed dose combination product Shuanghe 2017-05-16 18:33
- Generic product of fixed dose combination product nobody 2017-05-16 19:17
- Generic product of fixed dose combination product varun9461 2017-11-30 11:03

Retention quantity for SFDA BABE studies nlpati 2017-11-22 07:32

BE based on Metabolite M.tareq 2017-10-22 00:32
- BE based on Metabolite Vineeth KE 2017-10-23 07:53
  - BE based on Metabolite jag009 2017-10-24 05:41
    - BE based on Metabolite nobody 2017-10-24 19:02
      - BE based on Metabolite jag009 2017-11-19 06:35

Colombia guidelines ananth 2017-11-16 10:50
- Do your homework first Helmut 2017-11-16 15:00

FDA guide methylphenidate oral ER tablet - subject-by-formulation has gone? nobody 2017-10-25 08:40
- FDA guide methylphenidate oral ER tablet - subject-by-formulation has gone? ElMaestro 2017-10-25 12:07
- FDA guide methylphenidate oral ER tablet - subject-by-formulation has gone? Achievwin 2017-10-26 16:35
  - FDA guide methylphenidate oral ER tablet - subject-by-formulation has gone? jag009 2017-10-27 05:40
- FDA guide methylphenidate oral ER tablet - subject-by-formulation has gone? jag009 2017-10-27 05:39

FDA guidance for bioanalytical run samar sameh 2017-10-22 16:19
- FDA guidance for bioanalytical run xiaodongwang 2017-10-23 10:42
- FDA guidance for bioanalytical run Ruba 2017-10-24 09:14

Outlier PK Study – Non Normal Distribution DaLoe 2017-10-19 10:50
- Outlier PK Study – Non Normal Distribution jag009 2017-10-20 06:33
- Normal Distribution: Japan only Helmut 2017-10-23 10:25

Ambulatory missing blood samples in EMEA study pash413 2017-10-13 13:10
- Ambulatory missing blood samples in EMEA study ElMaestro 2017-10-15 16:56
- Excluding PK-metric(s) instead of subjects Helmut 2017-10-16 10:41

How to waive bridging studies by statistical calculations? Ebru Bozkurt 2017-10-12 14:31
- How to waive bridging studies by statistical calculations? DavidManteigas 2017-10-12 19:04

BA BE Study with a reference not market authorised Rick 2017-10-10 16:20
- BA BE Study with a reference not market authorised ElMaestro 2017-10-10 17:09
  - BA BE Study with a reference not market authorised Rick 2017-10-11 09:07

Patient population for bioequivalence study pash413 2017-10-04 15:44
- Patient population for bioequivalence study DavidManteigas 2017-10-06 10:34
  - Patient population for bioequivalence study pash413 2017-10-06 15:33

Exploratory pilot studies without filing IND jag009 2017-10-02 16:12

Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
244 visitors (0 registered, 244 guests [including 23 identified bots]).
Forum time: 16:07 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something. Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz